Pharmaceutical composition comprising a GPR119 agonist in combination with a dpp-4 inhibitor selected from a defined Group; use to prevent and / or treating Metabolic Diseases such as insulin resistance, diabetes, obesity, hyperlipidemia, metabolic syndrome, osteoporosis, among others.

摘要

Pharmaceutical composition comprising a GPR119 agonist in combination with a dpp-4 inhibitor; use of the pharmaceutical composition to treat and / or prevent Metabolic Diseases such as dIabetes, hyperlipidemia, insulin resistance, obesity, among others.